Eva A. Berkes, MD, is a physician-scientist and biotechnology leader specializing in allergy, asthma, immunology, microbiome science, and translational human health research. She is Co-Founder and Chief Scientific Officer of Quorum Innovations, where she leads research on host–microbiome interactions, biofilm biology, epithelial barrier protection, and biologically based strategies to mitigate micro- and nanoplastic interactions with human tissues. Dr. Berkes received her undergraduate degree from Williams College and her medical degree from the University of Florida. She completed residency training in internal medicine at the University of Florida and fellowship training in allergy, asthma, and immunology at Scripps Clinic and Research Institute. Her work integrates clinical insight with mechanistic and translational research and includes interests in mucosal defense, chronic inflammation, allergic disease, and barrier health. Through her scientific and entrepreneurial leadership, she has contributed to innovative approaches addressing contemporary environmental and biomedical challenges.
Eva A. Berkes, MD, is a physician-scientist and biotechnology leader specializing in allergy, asthma, immunology, microbiome science, and translational human health research. She is Co-Founder and Chief Scientific Officer of Quorum Innovations, where she leads research on host–microbiome interactions, biofilm biology, epithelial barrier protection, and biologically based strategies to mitigate micro- and nanoplastic interactions with human tissues. Dr. Berkes received her undergraduate degree from Williams College and her medical degree from the University of Florida. She completed residency training in internal medicine at the University of Florida and fellowship training in allergy, asthma, and immunology at Scripps Clinic and Research Institute. Her work integrates clinical insight with mechanistic and translational research and includes interests in mucosal defense, chronic inflammation, allergic disease, and barrier health. Through her scientific and entrepreneurial leadership, she has contributed to innovative approaches addressing contemporary environmental and biomedical challenges.